Baş-Boyun Karsinosarkomları
Özet
Baş-boyun karsinosarkomları, hem epitelyal hem de mezenkimal bileşenler barındıran ve genellikle agresif seyir gösteren nadir malign tümörlerdir. Bu tümörler, baş-boyun bölgesindeki skuamöz hücreli karsinomların oldukça küçük bir yüzdesini oluşturmakta ve sıklıkla larenks, oral kavite, orofarenks ile sinonazal bölgede ortaya çıkmaktadır. Patogenezinde epitelyal-mezenkimal geçiş mekanizmalarının rol oynadığı düşünülen bu neoplazmlar, ileri yaş grubunda ve erkeklerde daha sık görülmekte olup, tütün ile alkol kullanımıyla da yakından ilişkilendirilmektedir. Tümörlerin anatomik yerleşim yerine göre spesifik bir evreleme sistemi bulunmamakta, mevcut TNM sınıflaması ve radyolojik görüntüleme yöntemleri kullanılmaktadır. Sinonazal teratokarsinosarkom, tükrük bezi karsinosarkomları ve odontojenik karsinosarkom gibi farklı alt tipleri bulunan bu hastalık grubu, yerleşim yerine göre değişken ve genellikle kötü bir prognoza sahiptir. Tedavi protokollerinde, tümörün agresif doğası nedeniyle cerrahi rezeksiyon ve ardından adjuvan radyoterapiyi içeren multimodal yaklaşımlar ön plana çıkmaktadır. Ancak literatürdeki vaka sayısının azlığı nedeniyle standart bir tedavi şeması bulunmamakta, kemoterapinin, immünoterapinin ve hedefe yönelik ajanların etkinliğini netleştirmek adına daha kapsamlı klinik araştırmalara ihtiyaç duyulmaktadır.
Carcinosarcomas of the head and neck are rare malignant tumors characterized by a biphasic nature containing both epithelial and mesenchymal components, typically demonstrating an aggressive clinical course. These tumors constitute a small percentage of conventional squamous cell carcinomas in the head and neck region, predominantly manifesting in the larynx, oral cavity, oropharynx, and sinonasal tract. Epithelial-mesenchymal transition is considered a hallmark mechanism in their pathogenesis, and they are frequently observed in males over sixty years of age, strongly associated with tobacco and alcohol consumption. There is no disease-specific staging system for carcinosarcomas; thus, clinical staging relies on site-specific TNM classifications supported by CT, MRI, and PET imaging. Subtypes such as sinonasal teratocarcinosarcoma, salivary gland carcinosarcoma, and odontogenic carcinosarcoma present distinct clinicopathological features and generally harbor a poor prognosis. Due to their aggressive behavior, multimodal treatment comprising radical surgical resection followed by adjuvant radiotherapy is recommended. However, establishing definitive consensus guidelines remains challenging due to the scarcity of documentation, indicating that comprehensive investigations regarding chemotherapy, immunotherapy, and targeted treatments are highly required.
Referanslar
El-Naggar AK, Chan JKC, Grandis JR, et al. WHO Classification of Head and Neck Tumours: International Agency for Research on Cancer; 2017.
Zhang M, Zhao LM, Li XM, et al. True carcinosarcoma of the larynx. J Laryngol Otol. 2013;127(1):100-103 DOI: 10.1017/S002221511200285X
Thompson LD, Wieneke JA, Miettinen M, et al. Spindle cell (sarcomatoid) carcinomas of the larynx: a clinicopathologic study of 187 cases. Am J Surg Pathol. 2002;26(2):153-170 DOI: 10.1097/00000478-200202000-00002
Pang A, Carbini M, Moreira AL, et al. Carcinosarcomas and Related Cancers: Tumors Caught in the Act of Epithelial-Mesenchymal Transition. J Clin Oncol. 2018;36(2):210-216 DOI: 10.1200/JCO.2017.74.9523
Zidar N, Gale N, Kojc N, et al. Cadherin-catenin complex and transcription factor Snail-1 in spindle cell carcinoma of the head and neck. Virchows Arch. 2008;453(3):267-274 DOI: 10.1007/s00428-008-0649-y
Zidar N, Bostjancic E, Gale N, et al. Down-regulation of microRNAs of the miR-200 family and miR-205, and an altered expression of classic and desmosomal cadherins in spindle cell carcinoma of the head and neck--hallmark of epithelial-mesenchymal transition. Hum Pathol. 2011;42(4):482-488 DOI: 10.1016/j.humpath.2010.07.020
Kojc N, Zidar N, Gale N, et al. Transcription factors Snail, Slug, Twist, and SIP1 in spindle cell carcinoma of the head and neck. Virchows Arch. 2009;454(5):549-555 DOI: 10.1007/s00428-009-0771-5
Bice TC, Tran V, Merkley MA, et al. Disease-Specific Survival with Spindle Cell Carcinoma of the Head and Neck. Otolaryngol Head Neck Surg. 2015;153(6):973-980 DOI: 10.1177/0194599815594360
Gerry D, Fritsch VA, Lentsch EJ. Spindle cell carcinoma of the upper aerodigestive tract: an analysis of 341 cases with comparison to conventional squamous cell carcinoma. Ann Otol Rhinol Laryngol. 2014;123(8):576-583 DOI: 10.1177/0003489414525337
Chang NJ, Kao DS, Lee LY, et al. Sarcomatoid carcinoma in head and neck: a review of 30 years of experience--clinical outcomes and reconstructive results. Ann Plast Surg. 2013;71 Suppl 1:S1-7 DOI: 10.1097/SAP.0000000000000069
Prieto-Granada CN, Xu B, Alzumaili B, et al. Clinicopathologic features and outcome of head and neck mucosal spindle cell squamous cell carcinoma. Virchows Arch. 2021;479(4):729-739 DOI: 10.1007/s00428-021-03117-2
Patel TD, Vazquez A, Plitt MA, et al. A case-control analysis of survival outcomes in sinonasal carcinosarcoma. Am J Otolaryngol. 2015;36(2):200-204 DOI: 10.1016/j.amjoto.2014.10.031
Lonneux M, Hamoir M, Reychler H, et al. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. J Clin Oncol. 2010;28(7):1190-1195 DOI: 10.1200/JCO.2009.24.6298
Misra P, Husain Q, Svider PF, et al. Management of sinonasal teratocarcinosarcoma: a systematic review. Am J Otolaryngol. 2014;35(1):5-11 DOI: 10.1016/j.amjoto.2013.04.010
Chapurin N, Totten DJ, Morse JC, et al. Treatment of Sinonasal Teratocarcinosarcoma: A Systematic Review and Survival Analysis. Am J Rhinol Allergy. 2021;35(1):132-141 DOI: 10.1177/1945892420959585
Ellis GL, Corio RL. Spindle cell carcinoma of the oral cavity. A clinicopathologic assessment of fifty-nine cases. Oral Surg Oral Med Oral Pathol. 1980;50(6):523-533 DOI: 10.1016/0030-4220(80)90436-3
Su HH, Chu ST, Hou YY, et al. Spindle cell carcinoma of the oral cavity and oropharynx: factors affecting outcome. J Chin Med Assoc. 2006;69(10):478-483 DOI: 10.1016/S1726-4901(09)70312-0
Mingo KM, Derakhshan A, Abdullah N, et al. Characteristics and Outcomes in Head and Neck Sarcomatoid Squamous Cell Carcinoma: The Cleveland Clinic Experience. Ann Otol Rhinol Laryngol. 2021;130(7):818-824 DOI: 10.1177/0003489420977778
Zhong JT, Xie XX, Zhou SH, et al. True hypopharyngeal carcinosarcoma: a case report and literature review. J Int Med Res. 2018;46(8):3446-3461 DOI: 10.1177/0300060518779528
Zheng Y, Xiao M, Tang J. Clinicopathological and immunohistochemical analysis of spindle cell carcinoma of the larynx or hypopharynx: A report of three cases. Oncol Lett. 2014;8(2):748-752 DOI: 10.3892/ol.2014.2172
Viswanathan S, Rahman K, Pallavi S, et al. Sarcomatoid (spindle cell) carcinoma of the head and neck mucosal region: a clinicopathologic review of 103 cases from a tertiary referral cancer centre. Head Neck Pathol. 2010;4(4):265-275 DOI: 10.1007/s12105-010-0204-4
Dai L, Fang Q, Li P, et al. Oncologic Outcomes of Patients With Sarcomatoid Carcinoma of the Hypopharynx. Front Oncol. 2019;9:950 DOI: 10.3389/fonc.2019.00950
Colizza A, Gilardi A, Greco A, et al. Carcinosarcomas of the larynx: systematic review of the literature of a rare nosologic entity. Eur Arch Otorhinolaryngol. 2022;279(3):1167-1173 DOI: 10.1007/s00405-021-07027-6
Ballo MT, Garden AS, El-Naggar AK, et al. Radiation therapy for early stage (T1-T2) sarcomatoid carcinoma of true vocal cords: outcomes and patterns of failure. Laryngoscope. 1998;108(5):760-763 DOI: 10.1097/00005537-199805000-00024
Talwar A, Patel E, Tam M, et al. Patterns of Care and Outcomes of Carcinosarcoma of the Major Salivary Glands. Otolaryngol Head Neck Surg. 2022:1945998221120646 DOI: 10.1177/01945998221120646
Gupta A, Koochakzadeh S, Neskey DM, et al. Salivary Carcinosarcoma: An Extremely Rare and Highly Aggressive Malignancy. Laryngoscope. 2020;130(5):E335-E339 DOI: 10.1002/lary.28183
Schuch LF, de Arruda JAA, Silva LVO, et al. Odontogenic carcinosarcoma: A systematic review. Oral Oncol. 2018;85:52-59 DOI: 10.1016/j.oraloncology.2018.08.017
